Hydrate Inhibitors Market Research Research Report Information By Type (Thermodynamic Inhibitors (THIs), Low-Dosage Hydrate Inhibitors (LDHIs)) Application (Onshore Operations, Offshore Operations) Forecast 2030

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 23

1.1 MARKET ATTRACTIVENESS ANALYSIS 25

1.1.1 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE 26

1.1.2 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION 27

1.1.3 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION 28

2 MARKET INTRODUCTION 29

2.1 DEFINITION 29

2.2 SCOPE OF THE STUDY 29

2.3 MARKET STRUCTURE 30

3 RESEARCH METHODOLOGY 31

3.1 RESEARCH PROCESS 31

3.2 PRIMARY RESEARCH 32

3.3 SECONDARY RESEARCH 33

3.4 MARKET SIZE ESTIMATION 34

3.5 FORECAST MODEL 35

3.6 LIST OF ASSUMPTIONS 36

4 MARKET INSIGHTS 37

5 MARKET DYNAMICS 42

5.1 INTRODUCTION 42

5.2 DRIVERS 43

5.2.1 INCREASING DEMAND FOR LOW-DOSAGE HYDRATE INHIBITORS IN THE OIL & GAS INDUSTRY 43

5.2.2 ADVANCEMENTS IN THE DRILLING OF GAS HYDRATES 43

5.2.3 DRIVERS IMPACT ANALYSIS 44

5.3 RESTRAINTS 44

5.3.1 ENVIRONMENTAL ISSUES ASSOCIATED WITH THE USE OF ANTI-AGGLOMERATE (AA) LDHI 44

5.3.2 RESTRAINTS IMPACT ANALYSIS 45

5.4 OPPORTUNITIES 45

5.4.1 INCREASING INVESTMENTS IN OIL & GAS EXPLORATION ACTIVITIES IN DEVELOPING ECONOMIES 45

5.4.2 RESEARCH & DEVELOPMENT OF ECO-FRIENDLY HYDRATE INHIBITORS 46

5.5 CHALLENGES 47

5.5.1 REQUIREMENT OF HIGH DOSAGE OF THERMODYNAMIC INHIBITORS 47

5.5.2 AVAILABILITY OF DEPRESSURIZATION METHOD FOR CONTROLLING HYDRATE FORMATION 47

5.6 TRENDS 47

5.6.1 SHIFT TOWARD RENEWABLE SOURCES OF ENERGY 47

5.7 COVID 19 IMPACT ANALYSIS 48

5.7.1 ECONOMIC IMPACT ON THE OVERALL INDUSTRY 48

5.7.2 IMPACT ON PRODUCTION 48

5.7.3 IMPACT ON HYDRATE INHIBITORS INDUSTRY 48

5.7.4 IMPACT ON SUPPLY CHAIN 48

5.7.4.1 IMPACT ON RAW MATERIALS 49

5.7.4.2 PRICE VARIATIONS OF KEY RAW MATERIALS/COMPONENTS 49

5.7.4.3 CASH FLOW CONSTRAINTS 49

5.7.5 IMPACT ON PRICING 49

5.7.6 IMPACT ON WORLD TRADE 49

6 MARKET FACTOR ANALYSIS 50

6.1 SUPPLY CHAIN ANALYSIS 50

6.1.1 RAW MATERIALS SUPPLIERS 51

6.1.1.1 RAW MATERIAL SUPPLIERS FOR THERMODYNAMIC INHIBITORS (THIS) 51

6.1.1.2 RAW MATERIAL SUPPLIERS FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHIS) 51

6.1.2 HYDRATE INHIBITOR PRODUCERS 51

6.1.3 DISTRIBUTION CHANNEL 52

6.1.4 APPLICATIONS 52

6.2 PORTER’S FIVE FORCES MODEL 53

6.2.1 THREAT OF NEW ENTRANTS 53

6.2.2 THREAT OF SUBSTITUTES 54

6.2.3 BARGAINING POWER OF SUPPLIERS 54

6.2.4 BARGAINING POWER OF BUYERS 54

6.2.5 INTENSITY OF COMPETITIVE RIVALRY 54

6.3 PRICING ANALYSIS – BY REGION (USD/TON), 2021 55

6.4 GLOBAL MANUFACTURERS MARKET CONCENTRATION RATIO 55

7 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE 56

7.1 INTRODUCTION 56

7.2 THERMODYNAMIC INHIBITORS (THI) 58

7.3 LOW-DOSAGE HYDRATE INHIBITORS (LDHI) 60

8 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION 62

8.1 INTRODUCTION 62

8.2 OFFSHORE OPERATIONS 64

8.3 ONSHORE OPERATIONS 65

9 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION 66

9.1 OVERVIEW 66

9.2 NORTH AMERICA 70

9.2.1 US 74

9.2.2 CANADA 78

9.3 EUROPE 82

9.3.1 GERMANY 87

9.3.2 UK 91

9.3.3 FRANCE 95

9.3.4 ITALY 99

9.3.5 RUSSIA 103

9.3.6 NORWAY 107

9.3.7 NETHERLANDS 111

9.3.8 POLAND 115

9.3.9 DENMARK 119

9.3.10 REST OF EUROPE 123

9.4 ASIA-PACIFIC 127

9.4.1 CHINA 132

9.4.2 JAPAN 136

9.4.3 INDIA 140

9.4.4 AUSTRALIA & NEW ZEALAND 144

9.4.5 INDONESIA 148

9.4.6 SOUTH KOREA 152

9.4.7 THAILAND 156

9.4.8 REST OF ASIA-PACIFIC 160

9.5 LATIN AMERICA 164

9.5.1 BRAZIL 169

9.5.2 MEXICO 173

9.5.3 ARGENTINA 177

9.5.4 REST OF LATIN AMERICA 181

9.6 THE MIDDLE EAST AND AFRICA 185

9.6.1 GCC 190

9.6.2 NIGERIA 194

9.6.3 IRAN 198

9.6.4 IRAQ 202

9.6.5 EGYPT 206

9.6.6 REST OF THE MIDDLE EAST AND AFRICA 210

10 COMPETITIVE LANDSCAPE 214

10.1 COMPETITIVE OVERVIEW 214

10.2 GLOBAL MARKET STRATEGY ANALYSIS 214

10.3 COMPETITIVE BENCHMARKING 215

10.4 COMPETITION DASHBOARD 216

11 COMPANY PROFILES 217

11.1 SCHLUMBERGER 217

11.1.1 COMPANY OVERVIEW 217

11.1.2 FINANCIAL OVERVIEW 218

11.1.3 PRODUCT OFFERINGS 218

11.1.4 KEY DEVELOPMENTS 218

11.1.5 SWOT ANALYSIS 219

11.1.6 KEY STRATEGIES 219

11.2 BAKER HUGHES, A GE COMPANY LLC 220

11.2.1 COMPANY OVERVIEW 220

11.2.2 FINANCIAL OVERVIEW 221

11.2.3 PRODUCT OFFERINGS 221

11.2.4 KEY DEVELOPMENTS 222

11.2.5 SWOT ANALYSIS 222

11.2.6 KEY STRATEGIES 222

11.3 BASF SE 223

11.3.1 COMPANY OVERVIEW 223

11.3.2 FINANCIAL OVERVIEW 224

11.3.3 PRODUCT OFFERINGS 224

11.3.4 KEY DEVELOPMENTS 225

11.3.5 SWOT ANALYSIS 225

11.3.6 KEY STRATEGIES 225

11.4 HALLIBURTON 226

11.4.1 COMPANY OVERVIEW 226

11.4.2 FINANCIAL OVERVIEW 226

11.4.3 PRODUCT OFFERINGS 227

11.4.4 KEY DEVELOPMENTS 227

11.4.5 SWOT ANALYSIS 227

11.4.6 KEY STRATEGIES 227

12 COMPANY PROFILES 228

12.1 HUNTSMAN INTERNATIONAL LLC 228

12.1.1 COMPANY OVERVIEW 228

12.1.2 FINANCIAL OVERVIEW 229

12.1.3 PRODUCT OFFERINGS 229

12.1.4 KEY DEVELOPMENTS 230

12.1.5 SWOT ANALYSIS 230

12.1.6 KEY STRATEGIES 230

12.2 ASHLAND 231

12.2.1 COMPANY OVERVIEW 231

12.2.2 FINANCIAL OVERVIEW 232

12.2.3 PRODUCT OFFERINGS 232

12.2.4 KEY DEVELOPMENTS 233

12.2.5 SWOT ANALYSIS 233

12.2.6 KEY STRATEGIES 233

12.3 ARKEMA 234

12.3.1 COMPANY OVERVIEW 234

12.3.2 FINANCIAL OVERVIEW 235

12.3.3 PRODUCT OFFERINGS 235

12.3.4 KEY DEVELOPMENTS 236

12.3.5 SWOT ANALYSIS 236

12.3.6 KEY STRATEGIES 236

12.4 EVONIK INDUSTRIES AG 237

12.4.1 COMPANY OVERVIEW 237

12.4.2 FINANCIAL OVERVIEW 238

12.4.3 PRODUCT OFFERINGS 238

12.4.4 KEY DEVELOPMENTS 239

12.4.5 SWOT ANALYSIS 239

12.4.6 KEY STRATEGIES 239

12.5 HUNTSMAN INTERNATIONAL LLC 240

12.5.1 COMPANY OVERVIEW 240

12.5.2 FINANCIAL OVERVIEW 241

12.5.3 PRODUCT OFFERINGS 241

12.5.4 KEY DEVELOPMENTS 242

12.5.5 SWOT ANALYSIS 242

12.5.6 KEY STRATEGIES 242

12.6 ASHLAND 243

12.6.1 COMPANY OVERVIEW 243

12.6.2 FINANCIAL OVERVIEW 244

12.6.3 PRODUCT OFFERINGS 244

12.6.4 KEY DEVELOPMENTS 245

12.6.5 SWOT ANALYSIS 245

12.6.6 KEY STRATEGIES 245

12.7 ARKEMA 246

12.7.1 COMPANY OVERVIEW 246

12.7.2 FINANCIAL OVERVIEW 247

12.7.3 PRODUCT OFFERINGS 247

12.7.4 KEY DEVELOPMENTS 248

12.7.5 SWOT ANALYSIS 248

12.7.6 KEY STRATEGIES 248

12.8 EVONIK INDUSTRIES AG 249

12.8.1 COMPANY OVERVIEW 249

12.8.2 FINANCIAL OVERVIEW 250

12.8.3 PRODUCT OFFERINGS 250

12.8.4 KEY DEVELOPMENTS 251

12.8.5 SWOT ANALYSIS 251

12.8.6 KEY STRATEGIES 251

12.9 ECOLAB 252

12.9.1 COMPANY OVERVIEW 252

12.9.2 FINANCIAL OVERVIEW 253

12.9.3 PRODUCTS OFFERED 253

12.9.4 KEY DEVELOPMENTS 254

12.9.5 SWOT ANALYSIS 254

12.9.6 KEY STRATEGIES 254

12.10 FINORIC LLC 255

12.10.1 COMPANY OVERVIEW 255

12.10.2 FINANCIAL OVERVIEW 255

12.10.3 PRODUCTS OFFERED 255

12.10.4 KEY DEVELOPMENTS 255

12.10.5 SWOT ANALYSIS 256

12.10.6 KEY STRATEGIES 256

12.11 OMNI INDUSTRIAL SOLUTIONS 257

12.11.1 COMPANY OVERVIEW 257

12.11.2 FINANCIAL OVERVIEW 257

12.11.3 PRODUCTS OFFERED 257

12.11.4 KEY DEVELOPMENTS 257

12.11.5 SWOT ANALYSIS 258

12.11.6 KEY STRATEGIES 258

12.12 TETRA TECHNOLOGIES, INC. 259

12.12.1 COMPANY OVERVIEW 259

12.12.2 FINANCIAL OVERVIEW 260

12.12.3 PRODUCTS OFFERED 260

12.12.4 KEY DEVELOPMENTS 261

12.12.5 SWOT ANALYSIS 261

12.12.6 KEY STRATEGIES 261

13 APPENDIX 262

13.1 REFERENCES 262

13.2 RELATED REPORTS 263

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 36

TABLE 2 MANUFACTURERS MARKET CONCENTRATION RATIO, BY REGION 55

TABLE 3 GLOBAL HYDRATE INHIBITORS, BY TYPE, 2019–2030 (USD THOUSAND) 56

TABLE 4 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 57

TABLE 5 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 58

TABLE 6 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 58

TABLE 7 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY REGION, 2019–2030

(USD THOUSAND) 59

TABLE 8 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY REGION, 2019–2030 (TONS) 59

TABLE 9 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 60

TABLE 10 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 60

TABLE 11 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY REGION, 2019–2030

(USD THOUSAND) 61

TABLE 12 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY REGION, 2019–2030 (TONS) 61

TABLE 13 GLOBAL HYDRATE INHIBITORS, BY APPLICATION, 2019–2030 (USD THOUSAND) 62

TABLE 14 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 63

TABLE 15 GLOBAL HYDRATE INHIBITORS MARKET FOR OFFSHORE OPERATIONS, BY REGION, 2019–2030 (USD THOUSAND) 64

TABLE 16 GLOBAL HYDRATE INHIBITORS MARKET FOR OFFSHORE OPERATIONS, BY REGION, 2019–2030 (TONS) 64

TABLE 17 GLOBAL HYDRATE INHIBITORS MARKET FOR ONSHORE OPERATIONS, BY REGION, 2019–2030 (USD THOUSAND) 65

TABLE 18 GLOBAL HYDRATE INHIBITORS MARKET FOR ONSHORE OPERATIONS, BY REGION, 2019–2030 (TONS) 65

TABLE 19 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION, 2022-2030(USD THOUSAND) 67

TABLE 20 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION, 2022-2030(TONS) 68

TABLE 21 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2022-2030(USD THOUSAND) 69

TABLE 22 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2022-2030(TONS) 69

TABLE 23 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2022-2030(USD THOUSAND) 69

TABLE 24 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2022-2030(TONS) 69

TABLE 25 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 70

TABLE 26 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (TONS) 70

TABLE 27 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 70

TABLE 28 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 70

TABLE 29 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 71

TABLE 30 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 71

TABLE 31 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 72

TABLE 32 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(TONS) 72

TABLE 33 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 73

TABLE 34 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 73

TABLE 35 US HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 74

TABLE 36 US HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 74

TABLE 37 US HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 75

TABLE 38 US HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 75

TABLE 39 US HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 76

TABLE 40 US HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 76

TABLE 41 US HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 77

TABLE 42 US HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 77

TABLE 43 CANADA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 78

TABLE 44 CANADA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 78

TABLE 45 CANADA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 79

TABLE 46 CANADA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 79

TABLE 47 CANADA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 80

TABLE 48 CANADA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 80

TABLE 49 CANADA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 81

TABLE 50 CANADA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 81

TABLE 51 EUROPE HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 82

TABLE 52 EUROPE HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (TONS) 82

TABLE 53 EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 83

TABLE 54 EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 83

TABLE 55 EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 84

TABLE 56 EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 84

TABLE 57 EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 85

TABLE 58 EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 85

TABLE 59 EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 86

TABLE 60 EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 86

TABLE 61 GERMANY HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 87

TABLE 62 GERMANY HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 87

TABLE 63 GERMANY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 88

TABLE 64 GERMANY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 88

TABLE 65 GERMANY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 89

TABLE 66 GERMANY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 89

TABLE 67 GERMANY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 90

TABLE 68 GERMANY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 90

TABLE 69 UK HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 91

TABLE 70 UK HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 91

TABLE 71 UK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 92

TABLE 72 UK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 92

TABLE 73 UK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 93

TABLE 74 UK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 93

TABLE 75 UK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 94

TABLE 76 UK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 94

TABLE 77 FRANCE HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 95

TABLE 78 FRANCE HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 95

TABLE 79 FRANCE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 96

TABLE 80 FRANCE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 96

TABLE 81 FRANCE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 97

TABLE 82 FRANCE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 97

TABLE 83 FRANCE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 98

TABLE 84 POLAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 98

TABLE 85 ITALY HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 99

TABLE 86 ITALY HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 99

TABLE 87 ITALY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 100

TABLE 88 ITALY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 100

TABLE 89 ITALY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 101

TABLE 90 ITALY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 101

TABLE 91 ITALY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 102

TABLE 92 ITALY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 102

TABLE 93 RUSSIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 103

TABLE 94 RUSSIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 103

TABLE 95 RUSSIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 104

TABLE 96 RUSSIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 104

TABLE 97 RUSSIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 105

TABLE 98 RUSSIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 105

TABLE 99 RUSSIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 106

TABLE 100 RUSSIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 106

TABLE 101 NORWAY HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 107

TABLE 102 NORWAY HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 107

TABLE 103 NORWAY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 108

TABLE 104 NORWAY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 108

TABLE 105 NORWAY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 109

TABLE 106 NORWAY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 109

TABLE 107 NORWAY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 110

TABLE 108 NORWAY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 110

TABLE 109 NETHERLANDS HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 111

TABLE 110 NETHERLANDS HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 111

TABLE 111 NETHERLANDS HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 112

TABLE 112 NETHERLANDS HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 112

TABLE 113 NETHERLANDS HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 113

TABLE 114 NETHERLANDS HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(TONS) 113

TABLE 115 NETHERLANDS HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 114

TABLE 116 NETHERLANDS HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 114

TABLE 117 POLAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 115

TABLE 118 POLAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 115

TABLE 119 POLAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 116

TABLE 120 POLAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 116

TABLE 121 POLAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 117

TABLE 122 POLAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 117

TABLE 123 POLAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 118

TABLE 124 POLAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 118

TABLE 125 DENMARK HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 119

TABLE 126 DENMARK HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 119

TABLE 127 DENMARK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 120

TABLE 128 DENMARK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 120

TABLE 129 DENMARK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 121

TABLE 130 DENMARK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 121

TABLE 131 DENMARK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 122

TABLE 132 DENMARK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 122

TABLE 133 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 123

TABLE 134 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 123

TABLE 135 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 124

TABLE 136 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 124

TABLE 137 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 125

TABLE 138 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(TONS) 125

TABLE 139 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 126

TABLE 140 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 126

TABLE 141 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 127

TABLE 142 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (TONS) 127

TABLE 143 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 128

TABLE 144 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 128

TABLE 145 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 129

TABLE 146 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 129

TABLE 147 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 130

TABLE 148 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 130

TABLE 149 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 131

TABLE 150 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 131

TABLE 151 CHINA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 132

TABLE 152 CHINA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 132

TABLE 153 CHINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 133

TABLE 154 CHINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 133

TABLE 155 CHINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 134

TABLE 156 CHINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 134

TABLE 157 CHINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 135

TABLE 158 CHINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 135

TABLE 159 JAPAN HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 136

TABLE 160 JAPAN HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 136

TABLE 161 JAPAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 137

TABLE 162 JAPAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 137

TABLE 163 JAPAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 138

TABLE 164 JAPAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 138

TABLE 165 JAPAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 139

TABLE 166 JAPAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 139

TABLE 167 INDIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 140

TABLE 168 INDIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 140

TABLE 169 INDIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 141

TABLE 170 INDIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 141

TABLE 171 INDIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 142

TABLE 172 INDIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 142

TABLE 173 INDIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 143

TABLE 174 INDIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 143

TABLE 175 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 144

TABLE 176 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 144

TABLE 177 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 145

TABLE 178 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(TONS) 145

TABLE 179 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE,

2019–2030 (USD THOUSAND) 146

TABLE 180 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE,

2019–2030 (TONS) 146

TABLE 181 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 147

TABLE 182 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 147

TABLE 183 INDONESIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 148

TABLE 184 INDONESIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 148

TABLE 185 INDONESIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 149

TABLE 186 INDONESIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 149

TABLE 187 INDONESIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 150

TABLE 188 INDONESIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 150

TABLE 189 INDONESIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 151

TABLE 190 INDONESIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 151

TABLE 191 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 152

TABLE 192 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 152

TABLE 193 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 153

TABLE 194 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 153

TABLE 195 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 154

TABLE 196 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 154

TABLE 197 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 155

TABLE 198 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 155

TABLE 199 THAILAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 156

TABLE 200 THAILAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 156

TABLE 201 THAILAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 157

TABLE 202 THAILAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 157

TABLE 203 THAILAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 158

TABLE 204 THAILAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 158

TABLE 205 THAILAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 159

TABLE 206 THAILAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 159

TABLE 207 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 160

TABLE 208 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 160

TABLE 209 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 161

TABLE 210 REST OF HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 161

TABLE 211 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE,

2019–2030 (USD THOUSAND) 162

TABLE 212 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE,

2019–2030 (TONS) 162

TABLE 213 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 163

TABLE 214 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 163

TABLE 215 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 164

TABLE 216 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (TONS) 164

TABLE 217 LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 165

TABLE 218 LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 165

TABLE 219 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 166

TABLE 220 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 166

TABLE 221 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 167

TABLE 222 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(TONS) 167

TABLE 223 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 168

TABLE 224 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 168

TABLE 225 BRAZIL HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 169

TABLE 226 BRAZIL HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 169

TABLE 227 BRAZIL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 170

TABLE 228 BRAZIL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 170

TABLE 229 BRAZIL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 171

TABLE 230 BRAZIL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 171

TABLE 231 BRAZIL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 172

TABLE 232 BRAZIL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 172

TABLE 233 MEXICO HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 173

TABLE 234 MEXICO HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 173

TABLE 235 MEXICO HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 174

TABLE 236 MEXICO HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 174

TABLE 237 MEXICO HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 175

TABLE 238 MEXICO HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 175

TABLE 239 MEXICO HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 176

TABLE 240 MEXICO HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 176

TABLE 241 ARGENTINA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 177

TABLE 242 ARGENTINA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 177

TABLE 243 ARGENTINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 178

TABLE 244 ARGENTINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 178

TABLE 245 ARGENTINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 179

TABLE 246 ARGENTINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 179

TABLE 247 ARGENTINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 180

TABLE 248 ARGENTINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 180

TABLE 249 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 181

TABLE 250 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 181

TABLE 251 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 182

TABLE 252 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(TONS) 182

TABLE 253 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE,

2019–2030 (USD THOUSAND) 183

TABLE 254 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE,

2019–2030 (TONS) 183

TABLE 255 REST OF LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 184

TABLE 256 REST OF LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 184

TABLE 257 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND) 185

TABLE 258 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030(TONS) 185

TABLE 259 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 186

TABLE 260 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 186

TABLE 261 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE,

2019-2030(USD THOUSAND) 187

TABLE 262 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE,

2019-2030(TONS) 187

TABLE 263 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE,

2019-2030(USD THOUSAND) 188

TABLE 264 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE,

2019-2030(TONS) 188

TABLE 265 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 189

TABLE 266 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 189

TABLE 267 GCC HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 190

TABLE 268 GCC HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 190

TABLE 269 GCC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 191

TABLE 270 GCC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(TONS) 191

TABLE 271 GCC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(USD THOUSAND) 192

TABLE 272 GCC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 192

TABLE 273 GCC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 193

TABLE 274 GCC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 193

TABLE 275 NIGERIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 194

TABLE 276 NIGERIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 194

TABLE 277 NIGERIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 195

TABLE 278 NIGERIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 195

TABLE 279 NIGERIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030

(USD THOUSAND) 196

TABLE 280 NIGERIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 196

TABLE 281 NIGERIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 197

TABLE 282 NIGERIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 197

TABLE 283 IRAN HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 198

TABLE 284 IRAN HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 198

TABLE 285 IRAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(USD THOUSAND) 199

TABLE 286 IRAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(TONS) 199

TABLE 287 IRAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(USD THOUSAND) 200

TABLE 288 IRAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 200

TABLE 289 IRAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 201

TABLE 290 IRAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 201

TABLE 291 IRAQ HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 202

TABLE 292 IRAQ HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 202

TABLE 293 IRAQ HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(USD THOUSAND) 203

TABLE 294 IRAQ HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(TONS) 203

TABLE 295 IRAQ HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(USD THOUSAND) 204

TABLE 296 IRAQ HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 204

TABLE 297 IRAQ HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 205

TABLE 298 IRAQ HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 205

TABLE 299 EGYPT HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 206

TABLE 300 EGYPT HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 206

TABLE 301 EGYPT HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(USD THOUSAND) 207

TABLE 302 EGYPT HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(TONS) 207

TABLE 303 EGYPT HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030

(USD THOUSAND) 208

TABLE 304 EGYPT HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 208

TABLE 305 EGYPT HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 209

TABLE 306 EGYPT HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 209

TABLE 307 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 210

TABLE 308 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 210

TABLE 309 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI),

BY TYPE, 2019-2030(USD THOUSAND) 211

TABLE 310 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI),

BY TYPE, 2019-2030(TONS) 211

TABLE 311 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI),

BY TYPE, 2019-2030(USD THOUSAND) 212

TABLE 312 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI),

BY TYPE, 2019-2030(TONS) 212

TABLE 313 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 213

TABLE 314 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 213

TABLE 315 COMPETITION DASHBOARD 216

TABLE 316 SCHLUMBERGER: PRODUCT OFFERINGS 218

TABLE 317 BAKER HUGHES, A GE COMPANY LLC: PRODUCT OFFERINGS 221

TABLE 318 BASF SE: PRODUCT OFFERINGS 224

TABLE 319 HALLIBURTON: PRODUCT OFFERINGS 227

TABLE 320 HUNTSMAN INTERNATIONAL LLC: PRODUCT OFFERINGS 229

TABLE 321 ASHLAND: PRODUCT OFFERINGS 232

TABLE 322 PRODUCT OFFERINGS 235

TABLE 323 EVONIK INDUSTRIES AG: PRODUCT OFFERINGS 238

TABLE 324 HUNTSMAN INTERNATIONAL LLC: PRODUCT OFFERINGS 241

TABLE 325 ASHLAND: PRODUCT OFFERINGS 244

TABLE 326 PRODUCT OFFERINGS 247

TABLE 327 EVONIK INDUSTRIES AG: PRODUCT OFFERINGS 250

TABLE 328 ECOLAB: PRODUCTS OFFERED 253

TABLE 329 FINORIC LLC: PRODUCTS OFFERED 255

TABLE 330 OMNI INDUSTRIAL SOLUTIONS: PRODUCTS OFFERED 257

TABLE 331 TETRA TECHNOLOGIES, INC: PRODUCTS OFFERED 260

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 24

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL HYDRATE INHIBITORS MARKET 25

FIGURE 3 GLOBAL HYDRATE INHIBITORS MARKET ANALYSIS, BY TYPE 26

FIGURE 4 GLOBAL HYDRATE INHIBITORS MARKET ANALYSIS, BY APPLICATION 27

FIGURE 5 GLOBAL HYDRATE INHIBITORS MARKET ANALYSIS, BY REGION 28

FIGURE 6 GLOBAL HYDRATE INHIBITORS MARKET: STRUCTURE 30

FIGURE 7 RESEARCH PROCESS 31

FIGURE 8 TOP-DOWN & BOTTOM-UP APPROACHES 34

FIGURE 9 NORTH AMERICA MARKET SHARE BY COUNTRY (2021 VS 2030) 37

FIGURE 10 EUROPE MARKET SHARE BY COUNTRY (2021 VS 2030) 38

FIGURE 11 ASIA-PACIFIC MARKET SHARE BY COUNTRY (2021 VS 2030) 39

FIGURE 12 LATIN AMERICA MARKET SHARE BY COUNTRY (2021 VS 2030) 40

FIGURE 13 MIDDLE EAST & AFRICA MARKET SHARE BY COUNTRY (2021 VS 2030) 41

FIGURE 14 MARKET DYNAMICS OF GLOBAL HYDRATE INHIBITORS MARKET 42

FIGURE 15 DRIVERS IMPACT ANALYSIS: LOW DOSAGE HYDRATE INHIBITORS MARKET 44

FIGURE 16 RESTRAINTS IMPACT ANALYSIS: GLOBAL HYDRATE INHIBITORS MARKET 45

FIGURE 17 SUPPLY CHAIN: GLOBAL HYDRATE INHIBITORS MARKET 50

FIGURE 18 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL HYDRATE INHIBITORS MARKET 53

FIGURE 19 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 56

FIGURE 20 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 57

FIGURE 21 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 62

FIGURE 22 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 63

FIGURE 23 GLOBAL HYDRATE INHIBITORS MARKET BY REGION, 2022-2030(USD THOUSAND) 67

FIGURE 24 GLOBAL HYDRATE INHIBITORS MARKET BY REGION, 2022-2030(TONS) 68

FIGURE 25 SCHLUMBERGER: FINANCIAL OVERVIEW SNAPSHOT 218

FIGURE 26 SCHLUMBERGER: SWOT ANALYSIS 219

FIGURE 27 BAKER HUGHES, A GE COMPANY LLC: FINANCIAL OVERVIEW SNAPSHOT 221

FIGURE 28 BAKER HUGHES, A GE COMPANY LLC: SWOT ANALYSIS 222

FIGURE 29 BASF SE: FINANCIAL OVERVIEW SNAPSHOT 224

FIGURE 30 BASF SE: SWOT ANALYSIS 225

FIGURE 31 HALLIBURTON: FINANCIAL OVERVIEW SNAPSHOT 226

FIGURE 32 HALLIBURTON: SWOT ANALYSIS 227

FIGURE 33 HUNTSMAN INTERNATIONAL LLC: FINANCIAL OVERVIEW SNAPSHOT 229

FIGURE 34 HUNTSMAN INTERNATIONAL LLC: SWOT ANALYSIS 230

FIGURE 35 ASHLAND: FINANCIAL OVERVIEW SNAPSHOT 232

FIGURE 36 ASHLAND: SWOT ANALYSIS 233

FIGURE 37 FINANCIAL OVERVIEW SNAPSHOT 235

FIGURE 38 SWOT ANALYSIS 236

FIGURE 39 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT 238

FIGURE 40 SWOT ANALYSIS 239

FIGURE 41 HUNTSMAN INTERNATIONAL LLC: FINANCIAL OVERVIEW SNAPSHOT 241

FIGURE 42 HUNTSMAN INTERNATIONAL LLC: SWOT ANALYSIS 242

FIGURE 43 ASHLAND: FINANCIAL OVERVIEW SNAPSHOT 244

FIGURE 44 ASHLAND: SWOT ANALYSIS 245

FIGURE 45 FINANCIAL OVERVIEW SNAPSHOT 247

FIGURE 46 SWOT ANALYSIS 248

FIGURE 47 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT 250

FIGURE 48 SWOT ANALYSIS 251

FIGURE 49 ECOLAB: FINANCIAL OVERVIEW SNAPSH 253

FIGURE 50 ECOLAB: SWOT ANALYSIS 254

FIGURE 51 FINORIC LLC: SWOT ANALYSIS 256

FIGURE 52 OMNI INDUSTRIAL SOLUTIONS: SWOT ANALYSIS 258

FIGURE 53 TETRA TECHNOLOGIES, INC: FINANCIAL OVERVIEW SNAPSHOT 260

FIGURE 54 TETRA TECHNOLOGIES, INC: SWOT ANALYSIS 261

LIST OF ABBREVIATION

Abbreviation Full Form

US United States

UK United Kingdom

ME&A Middle East & Africa

RoW Rest of the World

CAGR Compound Annual Growth Rate